Inactive Instrument

Press Releases Neuropathix, Inc.

Equities

NPTX

US64132Q1094

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

NEUROPATHIX, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-05-23	AQ
Neuropathix : OTC Certification - Neuropathix, Inc. - FYE 2021	22-04-25	PU
NEUROPATHIX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	22-04-15	AQ
NEUROPATHIX, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-03-25	AQ
NEUROPATHIX, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21-11-12	AQ
NEUROPATHIX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	21-09-28	AQ
NEUROPATHIX : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21-08-06	AQ
Neuropathix : Neuropathix, Inc.	21-07-20	AQ
NEUROPATHIX : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21-05-13	AQ
Neuropathix, Inc. Announces Publication of Validated Preclinical Studies on KLS-13019 in the British Journal of Pharmacology	21-05-06	GL
NEUROPATHIX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	21-03-30	AQ
NEUROPATHIX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21-03-17	AQ
NEUROPATHIX, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	21-02-23	AQ
Neuropathix, Inc. CEO Recaps 2020 Advances and Potential Ahead	21-01-25	GL
Neuropathix : Announces Publication of Its Global PCT Patent for NPTX-204, a Novel Hops-Inspired Neuroprotectant	21-01-19	AQ
Neuropathix : Appoints World-Renowned Pain Management Clinician Dr. Daniel Richman to the Company’s Scientific Advisory Board	21-01-12	AQ
NEUROPATHIX, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-12-21	AQ
Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate	20-12-21	GL
Cannabinoid series: a CBD-inspired molecule to increase bioavailability	20-11-26	AQ
Neuropathix, Inc. Signs Binding Letter of Intent to Acquire Anticonvulsant – Neuroprotective Intellectual Property	20-11-19	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Neuropathix, Inc.

Equities

NPTX

US64132Q1094

Press Releases

Filters